AFP and hepatocellular carcinoma: AFP is a well-characterized biomarker for diagnosis, pathological grade, progression, and survival of HCC patients14, whereas cirrhosis, on the other hand, is a well-known intermediate stage in the progression from chronic liver disease and fibrosis to liver tumorigenesis15.